Ascenion Rebekka combines in-depth scientific expertise with industry and market experience. She joined Ascenion in 2023 as a Technology Scout, where she collaborates with scientists from research institutes and university hospitals to help advance their projects towards application. Before joining Ascenion, Rebekka spent over seven years at Sanofi, where she held various medical and marketing roles managing different Rx products in Germany and Switzerland. In her last position as Brand Manager at Sanofi, she was responsible for the company’s hematology portfolio and led the launch of a new multiple myeloma therapy in the German market.
Rebekka holds a PhD in Molecular Medicine from the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. Her doctoral research investigated the molecular mode of action of a novel anti-cancer drug candidate, which is now being developed by a clinical-stage spin-off from NTNU.